Log in
E-mail
Password
Show password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON
  1. Homepage
  2. Equities
  3. Japan
  4. Japan Exchange
  5. COSMOS Pharmaceutical Corporation
  6. News
  7. Summary
    3349   JP3298400007

COSMOS PHARMACEUTICAL CORPORATION

(3349)
  Report
SummaryChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsOther languagesPress ReleasesOfficial PublicationsSector newsMarketScreener Strategies

COSMOS PHARMACEUTICAL CORP : Ex-dividend day for final dividend

05/29/2018 EDT

A final dividend is removed today from Cosmos Pharmaceutical Corp's share.



ę Factset 2018
All news about COSMOS PHARMACEUTICAL CORPORATION
07/13Topix closes at near one-month high as investors await earnings
RE
05/28COSMOS PHARMACEUTICAL CORPORATION : Ex-dividend day for final dividend
FA
2020COSMOS PHARMACEUTICAL CORPORATION : Ex-dividend day for interim dividend
FA
2020COSMOS PHARMACEUTICAL CORPORATION : SPLIT: 2 of 1
FA
2020COSMOS PHARMACEUTICAL CORPORATION : Ex-dividend day for final dividend
FA
2019COSMOS PHARMACEUTICAL CORP : Ex-dividend day for interim dividend
FA
2019COSMOS PHARMACEUTICAL CORP : Ex-dividend day for final dividend
FA
2018COSMOS PHARMACEUTICAL CORP : Ex-dividend day for interim dividend
FA
2018COSMOS PHARMACEUTICAL CORP : Ex-dividend day for final dividend
FA
2018Hidefuji Co., Ltd. acquired 5.25% stake in COSMOS Pharmaceutical Corporation from Masat..
CI
More news
Financials
Sales 2022 761 B 6 683 M 6 683 M
Net income 2022 25 234 M 222 M 222 M
Net cash 2022 59 026 M 518 M 518 M
P/E ratio 2022 27,4x
Yield 2022 0,42%
Capitalization 691 B 6 072 M 6 069 M
EV / Sales 2022 0,83x
EV / Sales 2023 0,76x
Nbr of Employees -
Free-Float 47,3%
Chart COSMOS PHARMACEUTICAL CORPORATION
Duration : Period :
COSMOS Pharmaceutical Corporation Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends COSMOS PHARMACEUTICAL CORPORATION
Short TermMid-TermLong Term
TrendsBearishNeutralNeutral
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 13
Last Close Price 17 450,00 JPY
Average target price 18 761,54 JPY
Spread / Average Target 7,52%
EPS Revisions
Managers and Directors
Hideaki Yokoyama President & Representative Director
Masateru Uno Chairman
Masahiro Iwashita Executive Officer & Manager-Information Systems
Masao Ueda Independent Outside Director
Futoshi Shibata Director & Manager-Corporate Planning
Sector and Competitors